# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-014133
Filing Date
2019-11-13
Accepted
2019-11-13 17:19:32
Documents
56
Period of Report
2019-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cpix-20190930.htm iXBRL | 10-Q | 1368750
2 | EX-31.1 | a2019q3-exhibit311.htm | EX-31.1 | 16449
3 | EX-31.2 | a2019q3-exhibit312.htm | EX-31.2 | 16458
4 | EX-32.1 | a2019q3-exhibit321.htm | EX-32.1 | 9174
| Complete submission text file | 0001628280-19-014133.txt |  | 4977143

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20190930.xsd | EX-101.SCH | 32369
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20190930_cal.xml | EX-101.CAL | 68526
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20190930_def.xml | EX-101.DEF | 121853
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20190930_lab.xml | EX-101.LAB | 383723
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20190930_pre.xml | EX-101.PRE | 245694
44 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20190930_htm.xml | XML | 815805

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 191215296
SIC: 2834 Pharmaceutical Preparations